pharmaceutical-market-research-reports-isr-v1

PHARMACEUTICAL MARKET RESEARCH REPORTS

Industry Standard Research – ISR Reports – is a full-service pharmaceutical market research company operating exclusively in the life sciences industry and a sister company of Pharmaceutical Online. Their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions. You’ll find links to their pharmaceutical market syndicated research reports below.

ISR's market research reports are produced using direct feedback from decision-makers, which enables ISR to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to their customers. Each report is available for to purchase online and you may also download free preview files. If you have any questions, please feel free to email info@ISRreports.com.

TRENDS AND MARKET OUTLOOK REPORTS

  • Oral Dosage Forms Market Overview and Outlook (3rd Edition)
    Oral Dosage Forms Market Overview and Outlook (3rd Edition)

    This market research report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what our survey respondents—all oral dose outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2024. Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to...

  • Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook
    Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook

    This market research report provides an overview of the current market dynamics in the small molecule sterile injectable manufacturing space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2022.

  • Sterile Injectable Drug Product Manufacturing Market Outlook (3rd Ed.)
    Sterile Injectable Drug Product Manufacturing Market Outlook (3rd Ed.)

    This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.

  • Pharmaceutical Excipient Market Overview and Outlook
    Pharmaceutical Excipient Market Overview and Outlook

    This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.

  • Development vs Commercial Outsourced Manufacturing Practices: Biologics
    Development vs Commercial Outsourced Manufacturing Practices: Biologics

    This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.

  • Development vs. Commercial Outsourced Manufacturing Practices: Small Molecule
    Development vs. Commercial Outsourced Manufacturing Practices: Small Molecule

    This report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.

  • Bioprocessing Market Trends and Outsourcing Dynamics: 2020-2025 (3rd Edition)

    This market research report affords readers the opportunity to gain insight into the bioprocessing market and where it’s heading. This report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what our survey respondents predict the marketplace will look like in five years.

  • Clinical Manufacturing Market Dynamics and Service Provider Benchmarking
    Clinical Manufacturing Market Dynamics and Service Provider Benchmarking

    This report provides an overview of the current market dynamics in the clinical manufacturing space as well as an outlook of what our survey respondents predict the marketplace will look like in 2022.

  • Cell & Gene Therapies Market Outlook
    Cell & Gene Therapies Market Outlook

    Outsourcing decision-makers for cell or gene therapies at sponsor organizations give an overview of the current market dynamics in the cell & gene therapies contract manufacturing space and predictions through 2026.

Interested In Custom Research?

CONTRACT MANUFACTURER QUALITY BENCHMARKING

Interested In Custom Research?

DEPARTMENT MODELS AND STRUCTURES

  • Benchmarking the Pharma Industry's Market Research Function
    Benchmarking the Pharma Industry’s Market Research Function

    ISR conducted five in-depth interviews and 31 online surveys with experienced market researchers in the biopharmaceutical space to gain a better grasp on the market research function. Research subjects shared their insights on the types of research performed, how their market research function is structured, and outsourcing behavior.

  • Development And Commercial Manufacturing Outsourcing Models
    Development And Commercial Manufacturing Outsourcing Models

    This market research report explores how sponsor organizations use contract manufacturers to streamline costs, better manage capacity, access scientific expertise, improve efficiencies and decrease time to market.

  • The CMC Function: Best Practices and Optimization
    The CMC Function: Best Practices and Optimization

    ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.

  • Benchmarking The Pharma Industry's Medical Science Liaison (MSL) Function
    Benchmarking The Pharma Industry’s Medical Science Liaison (MSL) Function

    This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...

Interested In Custom Research?

ISR ARTICLES

  • Small Molecule Sterile Injectable Outsourcing Volume

    In Q2 2021, ISR asked 57 respondents how many small molecule sterile injectable products they have on the market, the proportion of sterile injectable manufacturing that is outsourced and the number of CDMOs they use to complete the work. On average, respondents have 3.4 marketed biologic products, of which 67% of drug product manufacturing is outsourced and use an average of 3.3 CDMOs.  To learn how these proportions are predicted to change in the next five years, follow the link to the Sterile Injectable Market Outlook report preview. 

  • Do Strategic Partnerships Meet Outsourcers Expectations?

    ISR’s CDMO Outsourcing Models report dives into three approaches to contracting manufacturing work, the motivations behind them, and which methods earn the greatest satisfaction among users.

  • Manufacturing Costs For Small Molecule Development Work

    In Q3 2020, ISR asked 49 respondents to allocate the costs of development work and clinical trial materials for outsourced small molecule drugs. The data show that API Manufacturing and Drug Product Manufacturing and Process Development capture similar proportions of outsourced spend at this stage. 

  • Outsourcer Engagement Preferences – No Love For Linkedin

    Despite the pandemic shifting away from in-person interaction, the data shows it has not had lasting impact on the preference for face-to-face communication with outsourcers.

  • Top 5 Oral Dosage Forms By Expenditure

    In Q2 2021, ISR asked 100 outsourcers of oral dose manufacturing to allocate the proportion of their company’s outsourced expenditure by dosage form. The data show that traditional tablets currently account for the largest proportion of spend, followed by controlled release tablets and immediate release tablets. However, respondents predict some of the current spend on tablets will shift to capsules five years from now. To learn more, follow the link to the Oral Dosage Forms Market Outlook report preview.

ABOUT ISR VIDEO

WHY ISR?

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive:

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.